Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/30/20177:20AMGlobeNewswire Inc.Analysis: Positioning to Benefit within Office Depot, ImmunoGen, Cedar Realty Trust, Carbo Ceramics, Consolidated Communicati...NASDAQ:IMGNImmunoGen Inc
11/09/20172:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
11/07/20173:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
11/03/20175:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/03/20175:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2017 Operating ResultsNASDAQ:IMGNImmunoGen Inc
11/01/20178:01AMBusiness WireImmunoGen to Present New Data on Novel Antibody-Drug Conjugates at 59th ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
10/20/20177:30AMBusiness WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2017 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/16/20177:00AMBusiness WireImmunoGen Announces Investigational New Drug Application for IMGN632 for Hematological Malignancies is ActiveNASDAQ:IMGNImmunoGen Inc
10/11/20173:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
10/11/20173:01PMBusiness WireImmunoGen Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase...NASDAQ:IMGNImmunoGen Inc
10/10/20179:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
10/10/20179:53AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
10/06/20173:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
10/06/20173:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMGNImmunoGen Inc
10/05/20177:30PMBusiness WireImmunoGen Announces Pricing of Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
10/04/20173:34PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMGNImmunoGen Inc
10/04/20173:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
10/04/20173:01PMBusiness WireImmunoGen Announces Proposed Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
10/03/20177:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/03/20177:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/03/20177:42AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/03/20177:41AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/26/20177:33AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/18/201710:17AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/15/20172:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/12/20177:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/05/20177:30AMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
09/01/20177:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/01/20177:00AMBusiness WireImmunoGen Announces Agreements to Exchange $76.4 Million of Its 4.50% Convertible Senior Notes Due 2021 for Common StockNASDAQ:IMGNImmunoGen Inc
08/29/20178:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

Delayed Upgrade Clock